Trial Search Results

Confounder-Corrected Quantitative MRI Biomarker of Hepatic Iron Content

The purpose of this multi-site research is to validate a rapid magnetic resonance based confounder-corrected R-2 mapping method as a quantitative imaging biomarker of liver iron concentrations.

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

University of Wisconsin, Madison

Collaborator: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Stanford Investigator(s):

Intervention(s):

  • Other: MRI

Eligibility


Inclusion Criteria:

   - know or suspected iron overload

Exclusion Criteria:

   - contraindication to magnetic resonance imaging

Ages Eligible for Study

10 Years - 89 Years

Genders Eligible for Study

All

Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Elisabeth Merkel, RN
650-736-0644
Recruiting